Craft
Livzon Pharmaceutical Group

Livzon Pharmaceutical Group

Revenue

¥11.8 B

FY, 2021

Market Capitalization

¥27.7 B

2023-01-19

Livzon Pharmaceutical Group Summary

Company summary

Overview
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. It specializes in gastrointestinal drugs, reproductive health, antibiotics, neurogeneration, psychotropic drugs, traditional Chinese medicine, immunomodulators, cardiovascular and cerebrovascular diseases drugs, anti-allergic drugs.
Type
Public
Status
Active
Founded
1985
HQ
Zhuhai, CN | view all locations
Website
https://www.livzon.com.cn/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Zhu Baoguo

    Zhu Baoguo, Chairman

    LocationsView all

    7 locations detected

    • Zhuhai, Guangdong Sheng HQ

      China

      38 Chuangye North Road

    • Chengdu, Sichuan Sheng

      China

      82 Longxing N St

    • Qingyuan, Guangdong Sheng

      China

      Renmin 1st Rd, Qingcheng Qu

    • Shanghai, Shanghai Shi

      China

      No. 1150 Guiqiao Road, Jinqiao Import And Export Processing Zone, Pudong New Area

    • Shaoguan, Guangdong Sheng

      China

      89 Gongye W Rd, Wujiang Qu

    • Shenzhen, Guangdong Sheng

      China

      Health Yuan Building, No. 17 - 2, Langshan Road, North District, Science And Technology Park

    and 1 others

    Livzon Pharmaceutical Group Financials

    Summary financials

    Revenue (Q3, 2022)
    ¥3.2B
    Gross profit (Q3, 2022)
    ¥2.1B
    Net income (Q3, 2022)
    ¥442.8M
    Cash (Q3, 2022)
    ¥9.6B
    EBIT (Q3, 2022)
    ¥381.6M
    Enterprise value
    $22.6B

    Footer menu